SEZ6L2 Antibody-Associated Cerebellar Ataxia Responsive to Sequential Immunotherapy.
Ayla MehdiyevaAki HietaharjuJussi O T SipiläPublished in: Neurology(R) neuroimmunology & neuroinflammation (2022)
This provides Class IV evidence. It is a single observational study without controls.
Keyphrases